Pharmacogenomics-Supported Psychotropic Prescribing Trial (NCT06929533)

🧪 Interventions in This Study

• Pharmacogenetic Testing (DIAGNOSTIC_TEST)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (2 Sites)

• Shared Health Facilities — Winnipeg, Manitoba
• University of Manitoba College of Pharmacy — Winnipeg, Manitoba

📞 Contact the Study Coordinator

Phone: (204) 318-2575

Email: abdullah.maruf@umanitoba.ca

Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Mental Disorder

• Enhancing Immune Health Randomized Controlled Trial — Chicago, Illinois
• CapExchange: A Pilot Feasibility Study of a Capacity-Exchange Programme for Mental Health Recovery — Saint-Claude,
• Validation of a VOICE MAnagement Program in Schizophrenia VVoice MAPS — Les Abymes,
• Healthy ReStart Intervention to Improve Health and Functioning — Chicago, Illinois

Explore by condition: All Mental Disorder clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Contact the study coordinator using the phone/email above.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.